Priority Date: 11.09.08 (US 20080191809P)

Method for identifying compounds useful for increasing the functional activity and cell surface expression of CF-associated mutant cystic fibrosis transmembrane conductance regulator

  • Application ID: EP14177377
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This patent has the IPC combination C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and G01 (MEASURING; TESTING) is specialized in the combination C12 and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Weidner Stern Jeschke, Zacco Denmark A/S and 92 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 11.09.2008 - Priority Date (US 20080191809P)
  • 24.12.2014 - Publication A2 (EP2816113)
  • 25.03.2015 - Publication A3 (EP2816113)